Evogene Q3 EPS $(0.00) Beats $(0.19) Estimate, Sales $141.000K Miss $365.000K Estimate
Benzinga Newsdesk 1 day ago
NewsEarningsEarnings BeatsEarnings Misses
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.00) per share which beat the analyst consensus estimate of $(0.19) by 100 percent. This is a 100 percent increase over losses of $(0.31) per share from the same
Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.00) per share which beat the analyst consensus estimate of $(0.19) by 100 percent. This is a 100 percent increase over losses of $(0.31) per share from the same period last year. The company reported quarterly sales of $141.000 thousand which missed the analyst consensus estimate of $365.000 thousand by 61.37 percent. This is a 54.81 percent decrease over sales of $312.000 thousand the same period last year.
